In addition, the glucose transporter GLUT1 mRNA has previously been shown to be a direct target of sd/miR-1291 in renal cell carcinoma (RCC), and Tu et al. confirmed this to be the case in pancreatic cancer cells as well with a resulting decrease in glycolytic capacity [61]. Here, SLC2A1 is linked to renal cell carcinoma.